Log on / register
Feedback | Support | My details
Open AccessStudy protocol

Implementation of outpatient schema therapy for borderline personality disorder: study design

Marjon Nadort1 email, Arnoud Arntz2 email, Johannes H Smit1 email, Josephine Giesen-Bloo2 email, Merijn Eikelenboom1 email, Philip Spinhoven4 email, Thea van Asselt5 email, Michel Wensing3 email and Richard van Dyck1 email

1GGZinGeest, Department of Psychiatry and Institute for Research in Extramural Medicine, VU University Medical Center Amsterdam, The Netherlands

2Maastricht University, Department of Clinical Psychological Science, The Netherlands

3Radboud University Nijmegen Medical Centre, Scientific Institute for Quality of Healthcare, The Netherlands

4Leiden University, Institute of Psychology and Department of Psychiatry, The Netherlands

5Maastricht University Medical Center, Department of Clinical Epidemiology and Medical Technology Assessment, The Netherlands

author email corresponding author email

BMC Psychiatry 2009, 9:64doi:10.1186/1471-244X-9-64

Published: 6 October 2009

Abstract

Background

Schema Therapy (ST) is an integrative psychotherapy based upon a cognitive schema model which aims at identifying and changing dysfunctional schemas and modes through cognitive, experiential and behavioral pathways. It is specifically developed for patients with personality disorders. Its effectiveness and efficiency have been demonstrated in a few randomized controlled trials, but ST has not been evaluated in regular mental healthcare settings. This paper describes the study protocol of a multisite randomized 2-group design, aimed at evaluating the implementation of outpatient schema therapy for patients with borderline personality disorder (BPD) in regular mental healthcare and at determining the added value of therapist telephone availability outside office hours in case of crisis.

Methods/Design

Patient outcome measures will be assessed with a semi-structured interview and self-report measures on BPD, therapeutic alliance, quality of life, costs and general psychopathology at baseline, 6, 12, 18 and 36 months. Intention-to-treat analyses will be executed with survival analysis for dichotomous variables, and one-sample t-tests and ANCOVAs for continuous variables with baseline as covariate and condition as between group factor. All tests will be two-tailed with a significance level of 5%.

Discussion

The study will provide an answer to the question whether ST can be effectively implemented and whether phone support by the therapist has an additional value.

Trial Registration

The Dutch Cochrane Center, NTR (TC = 1781).


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.